| Siwen Liu,Rong Ma,Haixia Cao,Dan Chen,Changwen Jing,Zhuo Wang,Junying Zhang,Yang Wu,Jifeng Feng,Jianzhong Wu. Prognostic significance of PD-L1 expression in patients with colorectal cancer: a meta-analysis. Oncol Transl Med, 2019, 5: 68-74. |
| Prognostic significance of PD-L1 expression in patients with colorectal cancer: a meta-analysis |
| Received:October 23, 2018 Revised:May 16, 2019 |
| View Full Text View/Add Comment Download reader |
| KeyWord:?colorectal cancer (CRC); programmed cell death ligand-1 (PD-L1); prognosis; Meta-analysis |
| Author Name | Affiliation | E-mail | | Siwen Liu | Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research ?& The Affiliated Cancer Hospital of Nanjing Medical University | siwenliu1989@126.com | | Rong Ma | Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research& The Affiliated Cancer Hospital of Nanjing Medical University | | | Haixia Cao | Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research ?& The Affiliated Cancer Hospital of Nanjing Medical University | | | Dan Chen | Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research ?DdDd The Affiliated Cancer Hospital of Nanjing Medical University | | | Changwen Jing | Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research ?DdDd The Affiliated Cancer Hospital of Nanjing Medical University | | | Zhuo Wang | Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research ?DdDd The Affiliated Cancer Hospital of Nanjing Medical University | | | Junying Zhang | Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research ?DdDd The Affiliated Cancer Hospital of Nanjing Medical University | | | Yang Wu | Research Center for Clinical Oncology, Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research ?DdDd The Affiliated Cancer Hospital of Nanjing Medical University | | | Jifeng Feng | Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated ?Cancer Hospital of Nanjing Medical University | | | Jianzhong Wu | ?Jiangsu Cancer Hospital DdDd Jiangsu Institute of Cancer Research DdDd The Affiliated Cancer Hospital of Nanjing Medical University | |
|
| Hits: 6178 |
| Download times: 7019 |
| Abstract: |
| ?Background The association between the expression of programmed cell death 1 (PD-1) or its ligand
[programmed cell death ligand-1 (PD-L1)] and colorectal cancer (CRC) survival rates remains unclear.
Thus, we conducted a meta-analysis to investigate the prognostic value of PD-L1 expression in CRC
patients.
Methods All eligible studies related to evaluation of PD-L1 expression and survival of CRC patients were
searched in PubMed, Medline, Cochrane library, and the EMBASE database. Hazard ratios (HRs) and 95%
confidence intervals (CI) of overall survival (OS) were examined to assess the effect of PD-L1 expression
on the survival of CRC patients. The outcomes of this meta-analysis were synthesized based on random-
effects model. Subgroup analyses were also performed.
Results Seven studies, wherein OS data were stratified according to the expression status of PD-L1,
were analyzed. CRC patients showing positive PD-L1 expression were associated with significantly poorer
prognoses in terms of overall survival, compared with those displaying negative PD-L1 expression (HR
= 1.43, 95% CI: 1.07–1.92; P = 0.02). In the subgroup analyses, H-scores as well as the percentage of
stained cells indicated that PD-L1 expression was significantly associated with poor prognosis (HR = 1.90,
95% CI: 1.38–2.62, P < 0.01; HR = 1.81, 95% CI: 1.08–3.03, P = 0.02). Immunohistochemical staining,
utilizing a rabbit anti-PD-L1 antibody, revealed significantly superior survival in the PD-L1 negative group
compared with the PD-L1 positive expression group (HR = 1.92; 95% CI, 1.40-2.63; P < 0.01). Moreover,
PD-L1 expression was significantly associated with poor prognosis when polyclonal antibodies were used
(HR = 1.84; 95% CI, 1.30–2.61; P < 0.01).
Conclusion Our meta-analysis indicated that PD-L1 expression status is a significant prognostic factor for
CRC patients. Positive PD-L1 expression was associated with worse CRC survival. Evaluation via different
immunohistochemistry based techniques may partly account for the contradictory results. Therefore, further
investigative studies using larger sample sizes are felt to be needed to elucidate the prognostic value of
PD-L1 expression in CRC patients. |
| Close |
|
|
|